Newsletter BOX: Deals Today

08/27/2013

Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between

Bradway's patient dealmaking brings Onyx to Amgen

New YORK (Reuters) - Investment banker turned biotech chief executive, Robert Bradway, staked a claim as a savvy dealmaker with Amgen Inc's successful acquisition of Onyx Pharmaceuticals Inc for more than $10 billion.

Eye drug firm Akorn to buy rival Hi-Tech Pharmacal for $640 million

(Reuters) - Specialty pharmaceutical company Akorn Inc will buy rival Hi-Tech Pharmacal Co Inc for $640 million in cash to expand its eye drug portfolio to other dosage forms such as oral liquids, topical creams and ointments.

Lloyds agrees to sell A$371 million loan parcel to Bain's Sankaty, says spokesman

SYDNEY (Reuters) - Britain's Lloyds Banking Group has agreed to sell a A$371 million ($335.74 million) portfolio of loan assets from its Australian unit BOS International Australia to Bain Capital's Sankaty Advisors for an undisclosed price, a Sankaty spokesman said in a statement.

China dairy group to seek approval for up to $1 billion HK IPO: IFR

HONG KONG (Reuters) - Chinese dairy company Liaoning Huishan Dairy Group plans to seek approval from the Hong Kong stock exchange on Thursday for an up to $1 billion initial public offering, IFR reported on Tuesday, citing sources familiar with the deal.

Telefonica wins Slim over with sweetened German deal

AMSTERDAM/MADRID (Reuters) - Telefonica has raised its bid for KPN's German arm by 6 percent to 8.55 billion euros ($11.5 billion), winning over top KPN investor America Movil and setting the stage for consolidation in Europe's largest mobile market.

Schulze plans to start selling Best Buy shares later this year

(Reuters) - Richard Schulze, the founder and largest shareholder of Best Buy Co Inc , has informed the world's largest consumer electronics chain about his plan to start selling its stock starting this fall, according to a regulatory filing on Monday.

Onyx deal expected to give Amgen a big boost

(Reuters) - Investors reacted favorably on Monday to Amgen Inc's $10.4 billion purchase of Onyx Pharmaceuticals Inc, which gives the world's largest biotech company full rights to a blood cancer drug with multibillion-dollar sales potential.

Exclusive: United Tech, Pentagon in $1 billion-plus deal for F-35 engines

WASHINGTON (Reuters) - Pratt & Whitney, a unit of United Technologies Corp, has reached an agreement in principle with the Pentagon on a contract to build 39 engines for a sixth batch of F-35 Joint Strike Fighters, three sources familiar with the deal said on Monday.

Landmark Chinese copper deal with Afghanistan at risk

KABUL (Reuters) - A consortium of Chinese investors has demanded a review of a landmark $3 billion deal to produce copper in Afghanistan, the Ministry of Mines said on Monday, putting at risk one of Kabul's greatest hopes for economic independence.

PE firm to take Globecomm private for $340 million

(Reuters) - Satellite communications provider Globecomm Systems Inc agreed to be taken private by investment firm Wasserstein & Co for about $340 million.